Nuzenio

Completes Patient Enrollment

Completes Patient Enrollment news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Opus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMTGlaukos completes enrollment in PRESERFLO MicroShunt pivotal study - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Tue, 04 Aug 2026 19:44:43 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+Eyewire+ · Tue, 04 Aug 2026 13:06:40 GMTVantage Biosciences Completes Enrollment in Phase 2 - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 11:00:00 GMTOpus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 07:38:27 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTOpus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 11:00:00 GMTOpus Genetics expects data in 2027 from one-time gene therapy trial - Stock TitanStock Titan · Mon, 03 Aug 2026 11:00:00 GMT

Timeline

Wed, 05 Aug 2026 19:39:16 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm International
Tue, 04 Aug 2026 19:44:43 GMTGlaukos completes enrollment in PRESERFLO MicroShunt pivotal study - Glance by Eyes On Eyecare
Tue, 04 Aug 2026 13:06:40 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+
Tue, 04 Aug 2026 11:00:00 GMTVantage Biosciences Completes Enrollment in Phase 2 - GlobeNewswire
Tue, 04 Aug 2026 07:38:27 GMTOpus Genetics Completes Enrollment in OPGx-LCA5 Phase 3 Trial - The Clinical Trial Vanguard
Mon, 03 Aug 2026 11:15:00 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Quiver Quantitative

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Completes Patient Enrollment.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.